We are live on
!
Find out more
Rafferty Asset Management Portfolio holdings
AUM
$24.6B
1-Year Est. Return
47.06%
This Fund
S&P 500
This Quarter
Est. Return
+3.36%
1 Year Est. Return
+47.06%
3 Year Est. Return
+108.18%
5 Year Est. Return
+135.84%
10 Year Est. Return
+427.13%
AUM
$24.6B
AUM Growth
-$4.32B
(-15%)
Cap. Flow
-$4.58B
Cap. Flow
% of AUM
-18.6%
Top 10 Holdings %
Top 10 Hldgs %
35.76%
Holding
1,158
New
25
Increased
204
Reduced
826
Closed
101
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares MSCI South Korea ETF
EWY
|
+$417M |
| 2 |
Tesla
TSLA
|
+$152M |
| 3 |
Broadcom
AVGO
|
+$74.2M |
| 4 |
Qualcomm
QCOM
|
+$39.4M |
| 5 |
Marvell Technology
MRVL
|
+$24.7M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares 20+ Year Treasury Bond ETF
TLT
|
+$647M |
| 2 |
iShares Russell 2000 ETF
IWM
|
+$341M |
| 3 |
Applied Materials
AMAT
|
+$243M |
| 4 |
Lam Research
LRCX
|
+$194M |
| 5 |
NVIDIA
NVDA
|
+$191M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 48.84% |
| 2 | Financials | 8.23% |
| 3 | Consumer Discretionary | 5.72% |
| 4 | Healthcare | 3.78% |
| 5 | Industrials | 3.33% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
BLSH
1026
Bullish
BLSH
$3.76B
| $201K | ﹤0.01% |
+5,637
| New | +$198K |
|
1027
Core Scientific
CORZ
$7.63B
| $174K | ﹤0.01% |
11,603
-2,741
| -19% | -$46.7K |
|
1028
Caleres
CAL
$396M
| $172K | ﹤0.01% |
16,360
-822
| -5% | -$9.8K |
|
1029
Cipher Digital
CIFR
$9.36B
| $168K | ﹤0.01% |
13,052
-3,214
| -20% | -$50.9K |
|
1030
Redwire
RDW
$2.25B
| $168K | ﹤0.01% |
+19,749
| New | +$193K |
|
|
PSKY
1031
Paramount Skydance Corp
PSKY
$9.55B
| $168K | ﹤0.01% |
18,601
-7,426
| -29% | -$81.2K |
|
1032
Smith & Wesson
SWBI
$679M
| $162K | ﹤0.01% |
11,321
+1,127
| +11% | +$13.7K |
|
1033
ThredUp
TDUP
$830M
| $162K | ﹤0.01% |
49,451
+6,126
| +14% | +$28.4K |
|
1034
Perrigo
PRGO
$1.45B
| $161K | ﹤0.01% |
14,955
-2,339
| -14% | -$30.3K |
|
1035
Groupon
GRPN
$989M
| $157K | ﹤0.01% |
13,152
-3,635
| -22% | -$48.5K |
|
|
SFIX
1036
Stitch Fix
SFIX
$512M
| $154K | ﹤0.01% |
46,647
-7,284
| -14% | -$29.7K |
|
|
ESPR
1037
DELISTED
Esperion Therapeutics
ESPR
| $149K | ﹤0.01% |
54,545
-6,500
| -11% | -$20.6K |
|
1038
Trevi Therapeutics
TRVI
$2.58B
| $147K | ﹤0.01% |
12,288
-4,211
| -26% | -$47.1K |
|
1039
Iris Energy
IREN
$14.8B
| $145K | ﹤0.01% |
4,242
-784
| -16% | -$35.4K |
|
1040
Amneal Pharmaceuticals
AMRX
$5.78B
| $143K | ﹤0.01% |
11,543
-7,605
| -40% | -$102K |
|
1041
Xeris Biopharma Holdings
XERS
$1.52B
| $141K | ﹤0.01% |
24,247
-9,442
| -28% | -$62.6K |
|
1042
Organon & Co
OGN
$3.55B
| $137K | ﹤0.01% |
22,923
-9,639
| -30% | -$72.5K |
|
1043
Nuvation Bio
NUVB
$2.24B
| $137K | ﹤0.01% |
31,964
+2,143
| +7% | +$11.9K |
|
|
CNH
1044
CNH Industrial
CNH
$12.8B
| $137K | ﹤0.01% |
12,466
-2,406
| -16% | -$27.1K |
|
1045
Ocular Therapeutix
OCUL
$1.96B
| $131K | ﹤0.01% |
15,443
+271
| +2% | +$2.58K |
|
1046
Savers
SVV
$1.48B
| $131K | ﹤0.01% |
17,571
-2,857
| -14% | -$27.3K |
|
1047
Omeros
OMER
$690M
| $130K | ﹤0.01% |
12,298
+72
| +0.6% | +$848 |
|
1048
EVgo
EVGO
$226M
| $116K | ﹤0.01% |
67,495
-6,154
| -8% | -$16.5K |
|
1049
CorMedix
CRMD
$643M
| $93.5K | ﹤0.01% |
13,775
-3,989
| -22% | -$29.5K |
|
1050
Marathon Digital Holdings
MARA
$4.67B
| $85.3K | ﹤0.01% |
10,458
-17,202
| -62% | -$156K |
|
Similar funds
CS
AF
SC
RG
JG
Rafferty Asset Management's Q1 2026 Portfolio in Review
As of Q1 2026, Rafferty Asset Management held 1,158 positions worth $24.6B, down 15% from $28.9B the previous quarter. Its ten largest holdings account for 36% of the portfolio.
Rafferty Asset Management withdrew a net $4.58B in Q1 2026, closing 101 positions and reducing 826 holdings. Its most notable exit was AstraZeneca, an estimated $12.3M position sold in full.
By sector, the portfolio is most concentrated in Technology at 49% of assets, up from 49% a quarter earlier, followed by Financials and Consumer Discretionary.
Against the trend, Rafferty Asset Management opened a new position in FTAI Aviation worth $6.39M.
- Rafferty Asset Management's largest Q1 2026 buy was FTAI Aviation: 26,098 shares worth $6.39M.
- Rafferty Asset Management added most to iShares MSCI South Korea ETF in Q1 2026, an estimated $417M increase.
- Rafferty Asset Management's biggest Q1 2026 reduction was iShares 20+ Year Treasury Bond ETF, cutting an estimated $647M.
- Rafferty Asset Management fully exited AstraZeneca in Q1 2026, selling an estimated $12.3M.
- Rafferty Asset Management's ten largest holdings make up 36% of its $24.6B portfolio in Q1 2026.
- Rafferty Asset Management opened 25 new positions and closed 101 in Q1 2026.
- Rafferty Asset Management's portfolio value fell 15% quarter-over-quarter to $24.6B.
Based on Rafferty Asset Management's 13F filing for Q1 2026, filed 15 May 2026.